← Back to all trials
Recruiting
NCT07717437
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
Conditions: Liver Cancer, Liver Metastases
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 350
Sponsor: Maastricht University Medical Center
Location: Rush University Medical Center Chicago Illinois
Summary
The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.
Eligibility Criteria
Inclusion Criteria:
* Patients who have undergone PVE/HVE or technical variations on this procedure
* 18 Years and older
* Men and women
Source: ClinicalTrials.gov (NCT07717437). StuddyBuddy aggregates publicly available trial information.
